Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
BMY Rating Summary
BMY Price Target Summary
- Highest: $92.00 (BMO Capital)
- Lowest: $61.00 (UBS)
- Average: $76.64
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$76.64 (-2.9%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 38%

Rating Score: 4.2 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/3/2022 | Raymond James | Dane Leone | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
75.07 (78.96) |
5.18% | Details |
5/2/2022 | CFRA | N/A | Downgrade | Sell (Hold) |
66.00 (N/A) |
77.20 (78.96) |
2.28% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |